JP2007326799A5 - - Google Patents

Download PDF

Info

Publication number
JP2007326799A5
JP2007326799A5 JP2006158442A JP2006158442A JP2007326799A5 JP 2007326799 A5 JP2007326799 A5 JP 2007326799A5 JP 2006158442 A JP2006158442 A JP 2006158442A JP 2006158442 A JP2006158442 A JP 2006158442A JP 2007326799 A5 JP2007326799 A5 JP 2007326799A5
Authority
JP
Japan
Prior art keywords
active oxygen
oxygen scavenging
galangin
phloretin
scavenging enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006158442A
Other languages
English (en)
Other versions
JP2007326799A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2006158442A priority Critical patent/JP2007326799A/ja
Priority claimed from JP2006158442A external-priority patent/JP2007326799A/ja
Publication of JP2007326799A publication Critical patent/JP2007326799A/ja
Publication of JP2007326799A5 publication Critical patent/JP2007326799A5/ja
Pending legal-status Critical Current

Links

Claims (4)

  1. ガランギン又はフロレチンのいずれか1種以上を含有する活性酸素消去酵素発現促進剤。
  2. 活性酸素消去酵素が、SODである請求項1記載の活性酸素消去酵素発現促進剤。
  3. ガランギン又はフロレチンのいずれか1種以上を含有する活性酸素の過剰産生によって誘発又は助長される症状若しくは疾患の予防、改善又は治療薬。
  4. ガランギン又はフロレチンのいずれか1種以上を含有する、活性酸素消去酵素発現促進作用を呈するものであることを特徴とし、生活習慣病の予防又は改善のために用いる旨の表示を付した飲食品。
JP2006158442A 2006-06-07 2006-06-07 活性酸素消去酵素発現促進剤 Pending JP2007326799A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006158442A JP2007326799A (ja) 2006-06-07 2006-06-07 活性酸素消去酵素発現促進剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006158442A JP2007326799A (ja) 2006-06-07 2006-06-07 活性酸素消去酵素発現促進剤

Publications (2)

Publication Number Publication Date
JP2007326799A JP2007326799A (ja) 2007-12-20
JP2007326799A5 true JP2007326799A5 (ja) 2009-03-05

Family

ID=38927525

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006158442A Pending JP2007326799A (ja) 2006-06-07 2006-06-07 活性酸素消去酵素発現促進剤

Country Status (1)

Country Link
JP (1) JP2007326799A (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005077A1 (ja) * 2008-07-11 2010-01-14 財団法人ヒューマンサイエンス振興財団 パーキンソン病の疾患関連たんぱく質およびその使用
WO2019238376A1 (en) * 2018-06-14 2019-12-19 Unilever Plc Foodstuff comprising a preservative
JP7166965B2 (ja) * 2019-03-13 2022-11-08 株式会社ファンケル bFGF発現増強用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651132B1 (fr) * 1989-08-30 1993-01-08 Pacific Chem Co Ltd Agents de protection des cellules contre les especes chimiques a oxygene actif et leur preparation.
FR2655268B1 (fr) * 1989-12-06 1994-10-14 Secma Utilisation d'extraits d'algues pour la preparation de compositions pharmaceutiques, cosmetiques, alimentaires ou a usage agricole.
FR2822466B1 (fr) * 2001-03-23 2004-07-02 Diana Ingredients Fraction phenolique riche en phloridzine et son utilisation en tant qu'agent cosmetique, alimentaire ou nutraceutique
JP2004161664A (ja) * 2002-11-13 2004-06-10 Fancl Corp プロポリス組成物
JP5596251B2 (ja) * 2005-10-14 2014-09-24 丸善製薬株式会社 皮膚化粧料及び頭髪化粧料
JP4954531B2 (ja) * 2005-10-31 2012-06-20 一丸ファルコス株式会社 ペルオキシソーム増殖剤応答性受容体活性化剤

Similar Documents

Publication Publication Date Title
JP2006219454A5 (ja)
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
JP2009084295A5 (ja)
TW200736213A (en) Dicarboxylic acid derivatives and their use
JP2009084294A5 (ja)
WO2008093793A1 (ja) 口腔内乾燥症の緩和または予防剤
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
JP2009541479A5 (ja)
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
WO2008120713A1 (ja) 副交感神経活動亢進作用を有する医薬組成物又は飲食物
TNSN08277A1 (en) Materials and methods for treating chronic fibrotic disease
WO2007087241A3 (en) Treatment of ischemic disease using thrombopoietin
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
GB2443793B (en) Product, method of manufacture and use
JP2012500261A5 (ja)
TNSN08279A1 (en) Bayer healthcare ag
BRPI0414347A (pt) associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade
WO2008071790A3 (en) Novel compositions and uses thereof
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
JP2007326799A5 (ja)
AR061233A1 (es) Formulacion de liberacion prolongada de naltrexona
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
JP2008266291A5 (ja)
JP2013032308A5 (ja)
JP2023010880A5 (ja) 疲労感、意欲低下または眠気の改善剤